FDA Approves Osphena (ospemifene) for Moderate to Severe Vaginal Dryness Due to Menopause

BLAINVILLE, QC, January 29, 2019– Duchesnay Inc., a pharmaceutical company specializing in women’s health, announced today that the FDA has approved its supplemental New Drug Application (sNDA) seeking to add moderate to severe vaginal...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news